Zurueck zur Suche

Reporte zur Charge UJ213AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 1

VAERS 2177636

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge UJ213AA

moderat
Staat
MI
Alter
88,0
Geschlecht
F
Eingang
14.03.2022
Impfdatum
29.10.2021
Beginn
04.02.2022
Tage bis Beginn
98,0
Dosis
3
Route/Site
- / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia COVID-19 Failure to thrive Fluid intake reduced General physical health deterioration Hypophagia Influenza A virus test negative Influenza B virus test Lethargy Pneumonia aspiration Respiratory syncytial virus test negative SARS-CoV-2 test positive Speech disorder Wheelchair user

Symptomtext

Source of Information: Available medical record History of Present Illness: This is a 88y.o. female with hx of dementia (AAOx1 per records), CHF, VTE on eliquis, Factor V Leiden, HTN, GERD who presents to Hospital via EMS from Facility with a chief complaint of failure to thrive per EMS report. Pt is currently nonverbal, lethargic therefore unable to obtain history from the patient. Called family member listed in chart, to obtain further history. At baseline, pt is perky, sits outside of her room and talks to the residents. She does not ambulate and uses a wheelchair at the facility. She reports the patient was diagnosed with COVID approximately two weeks ago and is supposed to be out of isolation now. She continued to be weak and was informed that the patient had pneumonia due to aspiration and the Facility wanted to start antibiotics. She states the Facility originally informed her that she was getting better and eating, however on 1/29, she was informed that she was pocketing food which progressed significantly to complete cessation of eating/drinking. She states the facility discussed initiation of a feeding tube and the guardian declined, stating it is too risky with her being on anticoagulation. She continued to decline in regards to PO status and informed today that she will go to the ED.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pneumonia aspiration
Hospital-Tage
13,0
Labordaten
NOCOVER> 1 HEALTH SYSTEM LABORATORY Chart Review Copy (88 yrs) PT CLASS: Inpatient CSN: DEPT: PATIENT STATUS: Discharged GENDER: female BED: ORD DR: AUTH DR: Results Covid-19, Flu, RSV by NAA Contains abnormal data Covid-19, Flu, RSV by NAA Order: Status: Final result Visible to patient: Yes (seen) Next appt: None Specimen Information: Nasopharyngeal; Swab 0 Result Notes Component Ref Range & Units Influenza A Not Detected Not Detected Influenza B Not Detected Not Detected RSV Not Detected Not Detected SARS-CoV-2 (COVID-19) by NAA, Micro Not Detected Detected Abnormal Narrative Methodology: Nucleic Acid Amplification(NAA)/Polymerase Chain Reaction(PCR) The SARS-CoV-2 (COVID-19) test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for laboratories certified under Agency to perform high complexity testing. This test has not been FDA cleared or approved. Specimen Collected: 02/04/22 4:21 PM Last Resulted: 02/04/22 5:24 PM
Aktuelle Erkrankungen
? Colon cancer ? GERD (gastroesophageal reflux disease) ? Hypertension ? Vascular disease
Vorgeschichte
? Colon cancer ? GERD (gastroesophageal reflux disease) ? Hypertension ? Vascular disease
Andere Medikamente
acetaminophen (TYLENOL) 325 MG PO Tab take 1 Tab by mouth every 8 hours as needed for FOR MODERATE PAIN or FOR SEVERE PAIN. Med Note ( Wed May 26, 2021 2:52 PM) amLODIPine (NORVASC) 10 MG PO Tab take 1 Tab by mouth once daily.
Allergien
No Known Drug Allergy
Vorherige Impfungen
-